Chromium (VI) promotes lung cancer initiation by activating EGF/ALDH1A1 signalling is a research paper published in Clinical and Translational Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: F30 CA236031
NCI NIH HHS
Grant: F30 CA236031
National Institutes of Health
Grant: 5F30CA236031-02
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
FWCI
0.16
Citation Percentile
0.4%
Citation Trend
Fields of Study
Keywords